Noitice - Meldonium / World Anti-Doping Agency (WADA). - 2016

A. Inclusion on the Prohibited List and excretions studies
B. Results management and adjudication
1. Results management shall proceed
2. Results management may be stayed
3. Cases where the concentration is below 1 μg/ml and the test was taken before 1 March 2016

Notice - Meldonium / World Anti-Doping Agency (WADA). - 2016

An updated guidance regarding the results management and adjudication process to be followed for cases involving meldonium.

- Urine Collection Date: from 1 January to 29 February 2016
- Urine Collection Date: from 1 March to 30 September 2016
- Urine Collection Date: after 30 September 2016

WADA - ONDCP Report to the United States Congress / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020

The World Anti-Doping Agency (WADA) was deeply disappointed to read the United States Office of National Drug Control Policy (ONDCP) Report regarding WADA funding that it submitted to the U.S. Congress on 17 June and that was made public.

As the U.S. has been a Foundation Board member of WADA since the creation of the Agency in 1999, WADA was particularly troubled by the fact that the ONDCP made allegations towards the Agency without due regard for the facts or context and without having raised any of these concerns during WADA Board meetings.

In Respons WADA sent an annotated version of the ONDCP Report to the Director of the ONDCP, asking him to kindly transmit this version to the U.S. Congress so that the Congress, and/or the appropriations committee, can deliberate and decide on WADA’s future funding based on accurate information. This annotated version outlines (in red) the misleading information and inaccuracies that the Report contains, and what the Report omits in terms of factual information.

Operation Refuge : An Examination of Doping Among Minors / World Anti-Doping Agency (WADA). - Montreal : WADA, 2024

Contents:

• Foreword
• Introduction
• Background
• Stories of Impact
• The ADO Perspective
• Testing and Results Management Data
• Intelligence Reporting
• Research Overview
• WADA Initiatives
• Conclusions
• Recommendations

‘Operation Refuge’ reports in detail about the deep trauma and isolation child athletes experience following a positive test and doping sanction. Undertaken by WADA’s Intelligence and Investigations Department, the report shines a light on the immense challenges faced by minors, their families and the anti-doping community when a child tests positive for a prohibited substance or method. The report delivers a number of conclusions and identifies important areas for improvement on this issue. 

In early 2021, WADA’s Confidential Information Unit (CIU) observed an increase in confidential reporting of doping activity amongst minors, including pre-teen athletes. While the lack of detail in many of these reports prevented substantive enforcement action, WADA followed up every case and launched investigations where appropriate. 

WADA was concerned by the nature and volume of reporting, leading to the commencement of ‘Operation Refuge’. It examined the doping activities of minors with a view to identifying any patterns of offending, any deficiencies in governance, and any possible strategies on how better to address the issue of doping amongst minors. 

A key aspect of ‘Operation Refuge’ was the firsthand accounts obtained from not only minors who had committed doping violations, but also their family and support networks. Although these experiences were shared with WADA on condition of anonymity, such was the impact of these accounts that permission was obtained from some to share their stories in the report. 

From the firsthand accounts that were obtained, six key themes emerged, namely: 

• Trauma; 
• Isolation; 
• Impact; 
• Pressure; 
• Ignorance, and; 
• Abandonment 

The report details information obtained from human intelligence (e.g., interviews, informants), data analysis, external academic study, open-source research, and the anti-doping community. 

Performance-Enhancing Drug Trafficking on the Dark Web / David Décary-Hétu; University of Montreal; World Anti-Doping Agency (WADA) . - Montreal : WADA, 2022

A year-long research project led by the World Anti-Doping Agency’s (WADA’s) independent Intelligence and Investigations (I&I) Department into the extent and nature of the trafficking of performance-enhancing drugs (PEDs) on the dark web has concluded that it is a marginal activity and very unlikely to be a significant source of drugs for high-level athletes or coaches.

This study was led by WADA I&I’s Confidential Information Unit in collaboration with the Agency’s Science Department and Professor David Décary-Hétu from the University of Montreal’s School of Criminology in Quebec, Canada. It was initiated in an effort to better understand the extent of PED trafficking on the dark web and to assess the type and quality of PEDs being trafficked there.

The main conclusions of the study reveal:

• It is very unlikely that high-level athletes would use this source for PED purchases; it attracts more low-level athletes, such as amateur or non-competitive bodybuilders.
• PED trafficking appears to be a marginal activity, both in absolute numbers and relative to the overall clear web and dark web underground economy. PED purchases represent only a small fraction of all dark web marketplace listings.
• Dark web PED trafficking favors small scale rather than bulk purchasing.
• There is no organized community of users exchanging information – the clear web remains a more active marketplace for the buying and selling of PEDs.
• Laboratory testing data suggests products are often mislabeled or contain major discrepancies in terms of their concentration. In 83% of transactions carried out for this study, the product and/or concentration received was not as advertised.
• Although significantly smaller in scope than the clear web, PED trafficking on the dark web appears to operate unchecked. The dark web affords actors the advantage of anonymity, which combined with weak regulations and a lack of enforcement, allows dark web PED suppliers the freedom to operate with relative impunity.

WADA - Play True Magazine
2002, issue 1
Play true!
----------------------------------------------------------------------------------
Content

Editorials
01 R.W. Pound

Features
01 Editorial: Play true!
02 WADA in brief
03 Glossary
04 Doping control
06 Awareness programme
08 Independent Observers
10 National Anti-Doping Organisations
13 World Anti-Doping Code
16 Interview
20 Sports Movement
22 Please contact us! + Schedule

WADA - Play True Magazine
2002, issue 3
The real meaning of Play True
----------------------------------------------------------------------------------
Content

Editorials
01 Harry Syväsalmi

Features
02 Inside WAMA
05 Glossary
06 World Anti-Doping Code
08 Doping Control / Science
10 Interview
13 Athletes
14 Communication / Education
16 National Anti-Doping Organisations
19 Sport Movement
21 Viewpoint
23 Dear Readers

WADA - Play True Magazine
2002, issue 2
We want heroes, not just winners!
----------------------------------------------------------------------------------
Content

Editorials
R.W. Pound

Features
02 Inside WADA
05 Glossary
06 Doping control
08 World Anti-Doping Code
09 Wada in Salt Lake City
12 Interview
14 Athletes
16 National Anti-Doping Organisations
18 Banbury Conference
20 Sport Movement
23 Dear Readers

WADA - Play True Magazine
2003, issue 1
A New Beginning for Sport - The World Conference on Doping in Sport ushers in an unprecedented new era of global anti-doping cooperation
----------------------------------------------------------------------------------
Content

Editorials
01 R.W. Pound: New Beginnings

Cover story
02 The World Conference on Doping in Sport
06 Conference Resolution

Conference Addresses
07 Richard Pound: Making History
09 Jacques Rogge: A Tough Stand
10 Paula Radcliffe: An Athlete's View

Conference Opinion
11 Kai Holm

Partner Profile
16 Australian Olympic Committee

WADA - Play True Magazine
2003, issue 3
Policy into Practice - With the World Anti-Doping Code now in effect, the guidelines for elite athletes have never been clearer. An in-depth look at WADA's role in the recently publiced Prohibited List of Substances, with special emphasis on the new harnomization of Therapeutic Use Exemptions
----------------------------------------------------------------------------------
Content

Profile
01 David Howman

Cover story
03 The Prohibited List & Therapeutic Use Exemptions

Features
07 Athlete Profile: Sergey Bubka
10 Partner Profile: FINA
12 UNESCO Convention Update
13 WADA Outreach: Destination All Africa Games
14 Olympic Museum Exhibit: Performance and Balance

WADA Updates
15 Code Update
15 Regional Offices
15 Funding Update
15 WADA-USADA Symposium
15 Journalist Symposium